- Previous Close
8.60 - Open
8.60 - Bid 8.60 x 70000
- Ask 8.80 x 70000
- Day's Range
8.60 - 8.60 - 52 Week Range
6.65 - 12.60 - Volume
3 - Avg. Volume
9 - Market Cap (intraday)
211.016M - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
6.06 - EPS (TTM)
1.42 - Earnings Date Aug 6, 2024 - Aug 13, 2024
- Forward Dividend & Yield 0.28 (3.25%)
- Ex-Dividend Date Sep 27, 2024
- 1y Target Est
--
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
www.fujipharma.jp1,621
Full Time Employees
September 30
Fiscal Year Ends
Sector
Recent News: FUP.F
View MorePerformance Overview: FUP.F
Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FUP.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FUP.F
View MoreValuation Measures
Market Cap
211.02M
Enterprise Value
362.17M
Trailing P/E
6.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
0.81
Enterprise Value/Revenue
1.44
Enterprise Value/EBITDA
5.45
Financial Highlights
Profitability and Income Statement
Profit Margin
13.75%
Return on Assets (ttm)
2.56%
Return on Equity (ttm)
14.01%
Revenue (ttm)
43.05B
Net Income Avi to Common (ttm)
5.92B
Diluted EPS (ttm)
1.42
Balance Sheet and Cash Flow
Total Cash (mrq)
1.38B
Total Debt/Equity (mrq)
61.97%
Levered Free Cash Flow (ttm)
-5.26B